Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Update for patients

We recognise that this is a very anxious time for people with diabetes and endocrine disorders.  As of 17 March 2020, the Government’s advice for people with diabetes, and for people taking hydrocortisone, prednisolone or other steroid replacement is to “be particularly stringent in following social distancing measures” to reduce transmission of the coronavirus (COVID-19). This involves reducing the social interaction you have with people.

There are several websites which provide up to date and clear information.  They include:

NHS: https://www.nhs.uk/conditions/coronavirus-covid-19/

The UK Government:      https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults

Diabetes UK: https://www.diabetes.org.uk/about_us/news/coronavirus

Society for Endocrinology:  https://www.endocrinology.org/news/item/14050/Coronavirus-advice-statement-for-patients-with-adrenal%2fpituitary-insufficiency

Association of British Clinical Diabetologists:        For Healthcare Professionals

                                                                               For People with Diabetes

Oxford University Hospitals is cancelling all routine Diabetes and Endocrinology appointments at present.  If you are awaiting a Day Case appointment you will be contacted by telephone.  All podiatry patients should attend as planned.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

EASD-Robert Turner Clinical Research Training Course

This interactive and highly successful course returns to the face-to-face format in 3-7 April 2022 for its 18th year.

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.